ArticleThe journal of pathology. Clinical research2018

IDK1 is a rat monoclonal antibody against hypoglycosylated bone sialoprotein with application as biomarker and therapeutic agent in breast cancer skeletal metastasis.

Michael Zepp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.